Aurelien Azam
Sanofi R&D
Chilly, France
Chilly, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Optimization of Single Relaxin B-Chain Peptide Leads to the Identification of R2R01, a Potent, Long-Acting RXFP1 Agonist for Cardiovascular and Renal Diseases.
Journal: Journal of medicinal chemistry
Published: January 31, 2025
Regulation of immune responses to therapeutic factor VIII by transplacental delivery of Fc-fused immunodominant factor VIII domains or peptides.
Journal: Haematologica
Published: November 27, 2024
R2R01: A long-acting single-chain peptide agonist of RXFP1 for renal and cardiovascular diseases.
Journal: British journal of pharmacology
Published: November 09, 2023
Transplacental delivery of therapeutic proteins by engineered immunoglobulin G: a step toward perinatal replacement therapy.
Journal: Journal of thrombosis and haemostasis : JTH
Published: January 01, 2023
Introduction of Non-natural Amino Acids Into T-Cell Epitopes to Mitigate Peptide-Specific T-Cell Responses.
Journal: Frontiers in immunology
Published: December 04, 2020
Specificity of the T Cell Response to Protein Biopharmaceuticals.
Journal: Frontiers in immunology
Published: January 31, 2020
Characterization of Proinsulin T Cell Epitopes Restricted by Type 1 Diabetes-Associated HLA Class II Molecules.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: September 03, 2019
Healthy Donors Exhibit a CD4 T Cell Repertoire Specific to the Immunogenic Human Hormone H2-Relaxin before Injection.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: June 18, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026